BeOne Medicines
ONC
#780
Rank
ยฃ23.26 B
Marketcap
ยฃ224.22
Share price
-3.77%
Change (1 day)
32.33%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2026 (TTM): ยฃ0.56 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are ยฃ5.73 Billion. In 2025 the company made an earning of ยฃ0.36 Billion, an increase over its 2024 earnings that were of -ยฃ0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ0.56 B55.79%
2025 ยฃ0.36 B-186.57%
2024 -ยฃ0.42 Billion-52.95%
2023 -ยฃ0.89 Billion-32.52%
2022 -ยฃ1.32 Billion24.39%
2021 -ยฃ1.06 Billion-13.21%
2020 -ยฃ1.23 Billion72.69%
2019 -ยฃ0.71 Billion36.01%
2018 -ยฃ0.52 Billion616.83%
2017 -ยฃ72.48 Million-15.24%
2016 -ยฃ85.51 Million107.91%
2015 -ยฃ41.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.12 Billion-121.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.37 Million-102.40%๐Ÿ‡บ๐Ÿ‡ธ USA